New approaches to the development of adenoviral dendritic cell vaccines in melanoma. - Wikidata - awgldk - TriplyDB

New approaches to the development of adenoviral dendritic cell vaccines in melanoma.

New approaches to the development of adenoviral dendritic cell vaccines in melanoma.

http://www.wikidata.org/entity/Q37820489

about

Human dendritic cells adenovirally-engineered to express three defined tumor antigens promote broad adaptive and innate immunity.Therapeutic effect of intratumoral administration of DCs with conditional expression of combination of different cytokines.Cytokine-induced killer cells promote antitumor immunity Engineering dendritic cells to enhance cancer immunotherapy.Transcriptional Targeting of Mature Dendritic Cells with Adenoviral Vectors via a Modular Promoter System for Antigen Expression and Functional Manipulation.Cellular immunity induced by a recombinant adenovirus- human dendritic cell vaccine for melanoma.The Journey of Virus Engineered Dendritic Cells From Bench to Bedside: A Bumpy Road

P2860

Q30426385-46B82609-F486-41BD-AF0D-30E290CB8A95 Q35741852-CFA9F068-ACAC-4815-A437-E0CC56CB2D94 Q36741617-C98DC021-8B09-4021-89C3-BA2A4D62D4D4 Q37862064-69FFE3F5-E897-46E8-B6FD-3E0654589C55 Q38756454-E24AF888-CC6F-49A1-9447-37F76811249C Q39575914-E51003C3-5192-4D3A-9C26-8CB26DC106DA Q58750585-959A0871-1BA5-4991-88E5-CE533F8448D6

P2860

New approaches to the development of adenoviral dendritic cell vaccines in melanoma.

http://www.wikidata.org/entity/Q37820489

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

New approaches to the development of adenoviral dendritic cell vaccines in melanoma.

@en

New approaches to the development of adenoviral dendritic cell vaccines in melanoma.

@nl

type

label

New approaches to the development of adenoviral dendritic cell vaccines in melanoma.

@en

New approaches to the development of adenoviral dendritic cell vaccines in melanoma.

@nl

prefLabel

New approaches to the development of adenoviral dendritic cell vaccines in melanoma.

@en

New approaches to the development of adenoviral dendritic cell vaccines in melanoma.

@nl

P1433

Q37820489-06EC6C45-8ABD-4ED0-AB59-9B3117F96812

P1476

Q37820489-22ABB37C-7E92-40E1-A35F-33376B297053

P2093

Q37820489-538D771E-D9C3-46FF-AD37-9E22FDDB0356

Q37820489-568D94C6-7413-4BD3-B5C4-89633D17455B

P2860

Q37820489-05523212-6982-4645-A1DE-028696F778A2

Q37820489-05EFA72A-3BAD-4B83-8F0E-8EB746D5194B

Q37820489-06F31894-0C3A-4017-91F5-39D2643B70FC

Q37820489-073EE60D-8C3F-414D-9D34-CA6103CE01C4

Q37820489-15D44345-73A7-4A0F-B084-07703147D03B

Q37820489-17D5C552-E223-4837-BCF6-2BAB3D3A2975

Q37820489-1812CB49-5445-4D2F-9E58-FDA6EB14B7A8

Q37820489-1A029375-4A7D-4584-BF1E-1198FCBED5D9

Q37820489-1B76D494-91ED-484A-AD70-AE16DAB11F49

Q37820489-1F18BBFD-FD1A-41A7-AB24-990A862A677E

P304

Q37820489-5E26AAAC-9394-4932-9914-481909986AEB

P31

Q37820489-0C3A8589-FA7B-4161-A30A-C260F3E22007

Q37820489-d1955550-f8db-4177-b8d8-e951a29ecbec

P433

Q37820489-CEA648AD-E726-4279-B301-790840F1788E

P478

Q37820489-8BB22250-631F-4E02-9C74-DA4366624945

P577

Q37820489-196BF6BC-0ACC-46B6-B07E-433AA9D5CDB7

P698

Q37820489-9A1B1876-9230-416D-BE1C-5F3C8489FFA3

P921

Q37820489-703594F3-227E-4FE6-B308-08C6836D90E8

P932

Q37820489-0FBE2529-6F6A-47EC-8912-F486CBE521AF

P1433

Current Opinion in Investigational Drugs

P1476

New approaches to the development of adenoviral dendritic cell vaccines in melanoma

@en

P2093

Lazar Vujanovic

http://www.w3.org/2001/XMLSchema#string

Lisa H Butterfield

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer immunotherapy: moving beyond current vaccines

Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells

Overexpression of CCL-21/secondary lymphoid tissue chemokine in human dendritic cells augments chemotactic activities for lymphocytes and antigen presenting cells

Dendritic cells and the control of immunity

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Cloning of a new cytokine that induces IFN-gamma production by T cells

Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment

The biology of chemokines and their receptors

Sequential immune escape and shifting of T cell responses in a long-term survivor of melanoma.

TAP1 down-regulation in primary melanoma lesions: an independent marker of poor prognosis.

P304

1399-1408

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2010-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21154122

http://www.w3.org/2001/XMLSchema#string

P921

P932

3758558

http://www.w3.org/2001/XMLSchema#string